Vesalius Biocapital offers venture capital
to young European innovative life science companies

logo
Portfolio

Activaero is the leading company in the field of controlled breathing technologies for inhaled therapeutic agents. It has two inhalation devices on the market and is in clinical stage development for a pharmaceutical product.

Amakem is using it’s Localized Drug Action platform for the development of kinase inhibitors. The primary focus is on eye disease.

A therapeutic vaccines and diagnostics company in the area of autoimmune and allergic diseases.

Biotechnological Enzymatic Catalyse - Bienca - develops, produces and commercializes enzymatic systems for food protection. It is one of the first companies in the world to propose bio-mimicry (technology inspired by nature) for food protection.

Complix is a developer of novel protein therapeutics based on its proprietary Alphabody technology.

Fovea Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of innovative drug products for disabling diseases of the eye.

GenKyoTex is a product-driven biopharmaceutical company dedicated to the development of innovative therapeutics blocking the source of production of oxygen radicals in a specific manner to meet unmet medical need.

Genomic Vision has developed a pioneering approach for genomic analyses called molecular combing technology, which allows the direct visualization of single DNA molecules. The company uses this approach to detect quantitave and qualitative changes in the genome linked to disease.

ProFibrix leverages its expertise in fibrinogen technology to develop and market innovative products for the hemostasis and regenerative medicine markets.

Promethere Biosciences is an innovative stem cell therapy company and a spin-off the Université Catholique de Louvain. It's mission is to develop novel cell-based products to treat incurable liver disease.

Skyline Diagnostics is a molecular diagnostic company developing tests for the classification of patients with blood cancers. The tests are standardized, automated and easy to use, thus allowing for a rapid, personalized treatment of each patient.

Trinean is a developer and producer of nanoliter spectrophotometers and consumables for the scientific market.